A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Clinical trial NCT07299825 · RECRUITING

Trial details

NCT number: NCT07299825
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Her 2 Positive Breast Cancer

Start date: 2024-09-20
Primary completion: 2027-09-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.